Global quantitative analysis of the human brain proteome in Alzheimer’s and Parkinson’s Disease (original) (raw)
Semiquantitative proteomic analysis of human hippocampal tissues from Alzheimer’s disease and age-matched control brains
Jochen Deckert
Clinical Proteomics, 2013
View PDFchevron_right
Quantitative proteomic analysis of the frontal cortex in Alzheimer’s disease
Abhay Moghekar
Journal of Neurochemistry, 2020
View PDFchevron_right
Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative disease
W. Caudle
2008
View PDFchevron_right
Insights into the changes in the proteome of Alzheimer disease elucidated by a meta-analysis
Sophia Schedin Weiss
Scientific Data, 2021
View PDFchevron_right
Proteome Profiling of Cerebrospinal Fluid Reveals Novel Biomarker Candidates for Parkinson’s Disease
Anne-marie Wills
2021
View PDFchevron_right
Label-Free Quantitative LC–MS Proteomics of Alzheimer’s Disease and Normally Aged Human Brains
Victor Andreev
Journal of Proteome Research, 2012
View PDFchevron_right
Targeted brain proteomics uncover multiple pathways to Alzheimer's dementia
Vladislav Petyuk
Annals of neurology, 2018
View PDFchevron_right
Gene expression meta-analysis of Parkinson’s disease and its relationship with Alzheimer’s disease
Rana Moyeed
Molecular Brain
View PDFchevron_right
Proteomic landscape of Alzheimer’s Disease: novel insights into pathogenesis and biomarker discovery
David Vanderwall
Molecular Neurodegeneration, 2021
View PDFchevron_right
Proteomics in Human Parkinson’s Disease: Present Scenario and Future Directions
Dr Rachna Mehta
Cellular and Molecular Neurobiology, 2019
View PDFchevron_right
Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for Alzheimer's Disease
Abhay Moghekar
PROTEOMICS – Clinical Applications, 2018
View PDFchevron_right
Identification of a novel proteomic Biomarker in Parkinson’s Disease: Discovery and Replication in Blood, brain and CSF
Jessica Ash
2021
View PDFchevron_right
CSF Multianalyte Profile Distinguishes Alzheimer and Parkinson Diseases
Kathryn Chung
American Journal of Clinical Pathology, 2008
View PDFchevron_right
Analysis of microdissected neurons by 18O mass spectrometry reveals altered protein expression in Alzheimer's disease
Nenad Bogdanovic
Journal of Cellular and Molecular Medicine, 2012
View PDFchevron_right
The Challenge to Search for New Nervous System Disease Biomarker Candidates: the Opportunity to Use the Proteogenomics Approach
Raphael Tavares
Journal of Molecular Neuroscience, 2018
View PDFchevron_right
A proteogenomic view of Parkinson’s disease causality and heterogeneity
Vinicius Sanz
npj Parkinson's Disease
View PDFchevron_right
Proteomics identification of proteins in human cortex using multidimensional separations and MALDI tandem mass spectrometer
Biaoyang Lin
Molecular & cellular proteomics : MCP, 2007
View PDFchevron_right
Next-generation profiling to identify the molecular etiology of Parkinson dementia
Winnie Liang
Neurology Genetics, 2016
View PDFchevron_right
Identification of Common Molecular Signatures Shared between Alzheimer’s and Parkinson’s Diseases and Therapeutic Agents Exploration: An Integrated Genomics Approach
Nairita Ahsan Faruqui
2021
View PDFchevron_right
Proteome analysis of human dorsolateral prefrontal cortex using shotgun mass spectrometry
Emmanuel Dias-Neto
Journal of Separation Science, 2008
View PDFchevron_right
Neuronal gene expression correlates of Parkinson's disease with dementia
Marwane Chelsea
Movement Disorders, 2008
View PDFchevron_right
Cerebrospinal fluid proteomic patterns discriminate Parkinson's disease and multiple system atrophy
Kei Tashiro
Movement Disorders, 2012
View PDFchevron_right
High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer's Disease in Human Cerebrospinal Fluid
Andy Liaw
PloS one, 2015
View PDFchevron_right
Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson’s disease
Anne-marie Wills
Cell Reports Medicine
View PDFchevron_right
High-Resolution Serum Proteomic Profiling of Alzheimer Disease Samples Reveals Disease Specific, Carrier-Protein-Bound Mass Signatures
Wayne Patton
2005
View PDFchevron_right
Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration
alessandra castegna
Journal of Neurochemistry, 2003
View PDFchevron_right
Evaluation of the Common Molecular Basis in Alzheimer’s and Parkinson’s Diseases
Edian Franco
International Journal of Molecular Sciences
View PDFchevron_right
Analysis of a membrane-enriched proteome from postmortem human brain tissue in Alzheimer's disease
Lenora Higginbotham
2012
View PDFchevron_right
Contribution of genomics and proteomics in understanding the role of modifying factors in Parkinson's disease
Dr. Madhu Dikshit
Indian journal of biochemistry & biophysics, 2006
View PDFchevron_right
Proteomic Biomarkers in Alzheimer's disease
Ramón Cacabelos
Diagnostic Pathology: Open Access, 2016
View PDFchevron_right
Brain site-specific proteome changes in aging-related dementia. Manavalan A, Mishra M, Feng L, Sze SK, Akatsu H, Heese K. Exp Mol Med. 2013 Sep 6;45:e39.
Klaus Heese
View PDFchevron_right
Brain site-specific proteome changes in aging-related dementia
Klaus Heese
Experimental & Molecular Medicine, 2013
View PDFchevron_right
From proteomics to biomarker discovery in Alzheimer's disease
Laurel Blackman
Brain Research Reviews, 2005
View PDFchevron_right